NCT01686815View on ClinicalTrials.gov

Cross-Sectional Iloperidone IVGTT

CompletedOBSERVATIONAL

Enrollment

37

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

SchizophreniaSerious Mental IllnessMetabolic SyndromeInsulin ResistanceGlucose Metabolism

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Massachusetts General Hospital

OTHER